Difference between revisions of "Example orders for simplified biweekly 5-FU & leucovorin (sLV5FU2) in colon cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth" to "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:200%"> Hello!<br> We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br> Please help us by filling it out!<br> '''Link:''' http://j.mp/2BlBaoQ </span> |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth") |
Warner-admin (talk | contribs) m (Text replacement - "Folinic acid (Leucovorin)" to "Leucovorin (Folinic acid)") |
||
| (15 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | |
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 17: | Line 10: | ||
===Example regimen #1=== | ===Example regimen #1=== | ||
| − | *[[Folinic acid | + | *[[Leucovorin (Folinic acid)]] 400 mg/m<sup>2</sup> IV over 2 hours on days 1 & 15, given first |
*[[Fluorouracil (5-FU)]] 400 mg/m<sup>2</sup> IV bolus over 10-15 minutes on day 1 after leucovorin | *[[Fluorouracil (5-FU)]] 400 mg/m<sup>2</sup> IV bolus over 10-15 minutes on day 1 after leucovorin | ||
| − | *[[Fluorouracil (5-FU)]] 1200 mg/ | + | *[[Fluorouracil (5-FU)]] 1200 mg/m<sup>2</sup>/day (total dose of 2400 mg/m<sup>2</sup>) IV continuous infusion over 46 hours on days 1 to 2, to start after 5-FU bolus |
'''28-day cycles''' | '''28-day cycles''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
| − | *Dexamethasone (Decadron) 12 mg PO 30 minutes prior to chemotherapy | + | *Dexamethasone (Decadron) 12 mg PO once; 30 minutes prior to chemotherapy |
| − | *Ondansetron (Zofran) 16 mg IV 30 minutes prior to chemotherapy | + | *Ondansetron (Zofran) 16 mg IV 30 minutes prior to chemotherapy |
*Lorazepam (Ativan) 0.5-1 mg PO prn nausea/anxiety, given 30 minutes prior to chemotherapy | *Lorazepam (Ativan) 0.5-1 mg PO prn nausea/anxiety, given 30 minutes prior to chemotherapy | ||
| Line 32: | Line 25: | ||
Monitoring: | Monitoring: | ||
| − | *Hold if ANC | + | *Hold if ANC less than 1500 or platelets less than 75 and notify physician. |
*Comprehensive metabolic panel (chem 10 & LFTs) before each treatment | *Comprehensive metabolic panel (chem 10 & LFTs) before each treatment | ||
*Monitor for possible hand-foot syndrome | *Monitor for possible hand-foot syndrome | ||
Latest revision as of 15:33, 29 September 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Simplified biweekly 5-FU & leucovorin (sLV5FU2)
Original references may be found at simplified biweekly 5-FU & leucovorin (sLV5FU2)
Example regimen #1
- Leucovorin (Folinic acid) 400 mg/m2 IV over 2 hours on days 1 & 15, given first
- Fluorouracil (5-FU) 400 mg/m2 IV bolus over 10-15 minutes on day 1 after leucovorin
- Fluorouracil (5-FU) 1200 mg/m2/day (total dose of 2400 mg/m2) IV continuous infusion over 46 hours on days 1 to 2, to start after 5-FU bolus
28-day cycles
Supportive therapy
- Dexamethasone (Decadron) 12 mg PO once; 30 minutes prior to chemotherapy
- Ondansetron (Zofran) 16 mg IV 30 minutes prior to chemotherapy
- Lorazepam (Ativan) 0.5-1 mg PO prn nausea/anxiety, given 30 minutes prior to chemotherapy
Hydration:
- 500 ml D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml D5W.
Monitoring:
- Hold if ANC less than 1500 or platelets less than 75 and notify physician.
- Comprehensive metabolic panel (chem 10 & LFTs) before each treatment
- Monitor for possible hand-foot syndrome
- Assess for mucositis at every visit
Comments:
- My institution administers this regimen in 28-day cycles.